%0 Journal Article
%T Comparison of International Regulations for Written Medicine Information (WMI) on Prescription Medicines
%A David K. Raynor
%A Hsiu-Chun Tony Yuan
%A Parisa Aslani
%J Therapeutic Innovation & Regulatory Science
%@ 2168-4804
%D 2019
%R 10.1177/2168479018776949
%X This paper presents a review of the literature, including government legislations, policies, guidelines, and recommendations available in the European Union, the United States of America, and Australia pertaining to the availability, development, and distribution of written medicine information (WMI) for prescription medicines. The online databases searched were Embase, International Pharmaceutical Abstracts, Medline, and PubMed, together with Google as the Internet search engine. The design and content of WMI documents have similarities and differences across all the 3 geographical regions. All the 3 regions have legislations in place to evaluate and regulate WMI documents for health care professionals (HCPs) and, to some degree, for patients; however, the degree of regulation varies between the 3 regions. The regulations around the content and information design of WMI impacts how well the WMI performs and consequently influences patients¡¯ knowledge and medication-taking behavior. Legislation in certain areas could be seen as more beneficial and can be implemented across the 3 regions. Furthermore, the required legislation on the evaluation of the content of WMIs can be seen in some areas to be more stringent and comprehensive, which when taken onboard across the 3 regions can be valuable when creating WMIs for both patients and HCPs
%K summary of product characteristics
%K package leaflet
%K package insert
%K consumer medication information
%K consumer medicine information
%K product information
%U https://journals.sagepub.com/doi/full/10.1177/2168479018776949